Chromadex Corp (CDXC) Stock Is Emerging from the Clouds
Oppenheimer raised the price target for the Chromadex Corp (NASDAQ:CDXC) stock from “an Outperform” to “a Perform”. The rating was released on August 16, 2022, according to finviz. We previously noted in another research note published on August 11, 2022 by B. Riley Securities that downgraded the stock from a Buy to a Neutral with […]
What is happening with Chromadex Corp (CDXC) Stock?
Oppenheimer raised the price target for the Chromadex Corp (NASDAQ:CDXC) stock from “an Outperform” to “a Perform”. The rating was released on August 16, 2022, according to finviz. We previously noted in another research note published on August 11, 2022 by B. Riley Securities that downgraded the stock from a Buy to a Neutral with […]
Using Chromadex Corp (CDXC) Stock as an income source, let’s make some money!
Oppenheimer raised the price target for the Chromadex Corp (NASDAQ:CDXC) stock from “an Outperform” to “a Perform”. The rating was released on August 16, 2022, according to finviz. We previously noted in another research note published on August 11, 2022 by B. Riley Securities that downgraded the stock from a Buy to a Neutral with […]
What does the future hold for Chromadex Corp (CDXC) Stock?
Oppenheimer raised the price target for the Chromadex Corp (NASDAQ:CDXC) stock from “an Outperform” to “a Perform”. The rating was released on August 16, 2022, according to finviz. We previously noted in another research note published on August 11, 2022 by B. Riley Securities that downgraded the stock from a Buy to a Neutral with […]
It’s not the right time to quit: Chromadex Corp (CDXC) Stock
Oppenheimer raised the price target for the Chromadex Corp (NASDAQ:CDXC) stock from “an Outperform” to “a Perform”. The rating was released on August 16, 2022, according to finviz. We previously noted in another research note published on August 11, 2022 by B. Riley Securities that downgraded the stock from a Buy to a Neutral with […]
